Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK)

Price 1,354.00p on 20-01-2025 at 17:30:00
Change -5.00p -0.37%
Buy 1,353.50p
Sell 1,353.00p
Buy / Sell GSK Shares
Last Trade: Sell 2,729.00 at 1,354.00p
Day's Volume: 3,752,809
Last Close: 1,354.00p
Open: 1,356.50p
ISIN: GB00BN7SWP63
Day's Range 1,352.00p - 1,364.50p
52wk Range: 1,282.50p - 1,820.00p
Market Capitalisation: £55,250m
VWAP: 1,356.96412p
Shares in Issue: 4,081m

Recent Trades History Glaxosmithkline (GSK)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 2,729 1,354.00p SI Trade
Suspected SELL Trade
16:49:08 - 20-Jan-25
Buy* 21,131 1,356.60424p Suspected BUY Trade
16:41:10 - 20-Jan-25
Unknown* 235,870 1,354.00p OTC Trade
16:35:27 - 20-Jan-25
Buy* 934,300 1,354.00p Suspected BUY Trade
16:35:27 - 20-Jan-25
Sell* 310 1,353.00p Automatic Execution
16:29:56 - 20-Jan-25
Sell* 272 1,353.00p Automatic Execution
16:29:54 - 20-Jan-25
Buy* 12 1,353.50p Automatic Execution
16:29:54 - 20-Jan-25
Sell* 340 1,353.00p Automatic Execution
16:29:49 - 20-Jan-25
Sell* 27 1,353.00p Automatic Execution
16:29:49 - 20-Jan-25
Buy* 20 1,353.50p Automatic Execution
16:29:43 - 20-Jan-25

Share Price History for Glaxosmithkline

Time period:
to
Date Open High Low Close Volume

Share News for Glaxosmithkline

LONDON BROKER RATINGS: Jefferies raises Spirax; Peel Hunt cuts Grainger

20th Jan 2025 09:56

(Alliance News) - The following London-listed shares received analyst recommendations on Monday morning and on Friday: Read More

GSK gets EU nod for expanded use of Jemperli in endometrial cancer

20th Jan 2025 08:40

(Alliance News) - GSK PLC on Monday said the European Commission has expanded approval for its drug Jemperli, in combination with chemotherapy, to include all adult patients with primary advanced or recurrent endometrial cancer eligible for systemic therapy. Read More

UPDATE: Pfizer cuts stake in Haleon to 7% in GBP2.5 billion share sale

15th Jan 2025 08:43

(Alliance News) - Pfizer Inc sold 700 million shares in Haleon PLC, as planned, more than halving its remaining stake, placing agent JPMorgan Securities PLC confirmed on Wednesday. Read More

Pfizer to more than halve Haleon holding in GBP2.57 billion sale

14th Jan 2025 17:24

(Alliance News) - Pfizer Inc is selling 700 million shares in Haleon PLC, more than halving its remaining stake, according to a statement from JPMorgan Securities on Tuesday. Read More

GSK to buy precision therapeutics firm IDRx for up to USD1.15 billion

13th Jan 2025 09:08

(Alliance News) - GSK PLC on Monday said it has agreed to acquire Boston, Massachusetts-based IDRx Inc in a deal that will add to its "growing portfolio in gastrointestinal cancers". Read More

FTSE 100 Latest
Value8,520.54
Change15.32

Login to your account

Forgot Password?

Not Registered